Full-Time

Director – Engineering

Clinical Products

Updated on 6/17/2025

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Compensation Overview

$220k - $290k/yr

+ Cash Bonus + Equity

Senior, Expert

San Francisco, CA, USA

Hybrid position; specific in-office days not mentioned.

Category
Applied Machine Learning
AI & Machine Learning
Required Skills
AWS
Development Operations (DevOps)
Requirements
  • Proven experience managing managers and leading multiple engineering teams in a fast-paced, mission-driven environment.
  • Track record of successful planning, consistent execution, and on-time delivery of complex software projects.
  • Strong leadership and organizational skills with an ability to align engineering outcomes to business priorities.
  • Experience in turning complex data and algorithms into intuitive, interactive visual experiences.
  • Strong background in UI/UX-driven development, data visualization, or real-time rendering.
  • Practical experience of turning research-developed algorithms into production-grade software.
  • Solid understanding of MLOps, cloud-native development, and scalable architectures.
  • Deep knowledge of software development best practices: testing, CI/CD, DevOps, agile methodologies.
  • Excellent communication and collaboration skills across cross-functional teams.
  • Experience with medical applications or other regulated industries. Direct experience with Software as a Medical Device (SaMD) is highly desired.
  • Experience with cloud-based infrastructures (Amazon Web Services or equivalent).
Responsibilities
  • Lead and grow multiple engineering teams through engineering managers, setting clear goals and ensuring alignment to strategic objectives.
  • Drive successful quarterly and long-range planning efforts, balancing innovation with execution, and ensuring engineering teams consistently meet delivery commitments.
  • Ensure engineering teams are executing with high quality, predictable velocity, and attention to operational reliability.
  • Hire, develop, and retain strong engineering and management talent; build an inclusive, high-performance team culture.
  • Manage and grow an organization of engineering teams that span algorithm development, visualizations, results and report generation.
  • Mentor and guide engineering managers in their career development and technical growth.
  • Provide technical leadership across medical device software, including visualization, UI architecture, cloud services, algorithm development and integration.
  • Collaborate with product, clinical, design, and research teams to build seamless and effective user experiences that translate complex data into actionable insights.
  • Partner with other engineering leaders to evolve our system architecture and ensure cross-team alignment and technical coherence.
  • Contribute hands-on to design when appropriate, especially in areas of high impact such as architecture, rendering pipelines, or clinical data visualization.
Desired Qualifications
  • Nice-to-have: experience with medical imaging or 3D visualization.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making diagnosis and treatment safer and more efficient.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$1B

Headquarters

Redwood City, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow's technology aligns with the growing trend of AI adoption in healthcare.
  • The global non-invasive cardiac imaging market is projected to grow significantly, benefiting HeartFlow.
  • Updated AHA guidelines emphasize non-invasive testing, increasing demand for HeartFlow's FFRCT Analysis.

What critics are saying

  • Emerging AI-driven cardiovascular tools could threaten HeartFlow's market share.
  • HeartFlow's reliance on continuous funding rounds indicates potential financial instability.
  • New regulatory requirements for AI in healthcare could necessitate costly adjustments for HeartFlow.

What makes HeartFlow unique

  • HeartFlow offers a unique AI-driven non-invasive cardiac test for coronary artery visualization.
  • The company's technology integrates over two decades of scientific evidence with AI advancements.
  • HeartFlow is the only provider offering both anatomical and physiological coronary artery visualization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-2%

2 year growth

-3%
Intelligence360
Apr 22nd, 2025
HeartFlow Raises $50M in Debt Financing

HeartFlow has filed a notice for an exempt offering of securities to raise $50 million in new debt financing. This filing with the U.S. Securities and Exchange Commission is required under federal securities law for companies selling securities without registration under the Securities Act of 1933, specifically under Rule 504 or 506 of Regulation D or Section 4(a)(5). The notice must be filed within 15 days after the first sale of securities in the offering.

Benzinga
Mar 26th, 2025
Heartflow Secures $98M in Funding

Heartflow, Inc. announced a $98 million convertible notes financing led by its parent company, Heartflow Holding, Inc. New and existing investors, including Fidelity Management, Janus Henderson, and Bain Capital, participated. The funds will support R&D to advance Heartflow's AI-driven coronary care platform. Heartflow's technology, recognized for innovation, aims to improve CAD diagnosis and management. The platform has been used for over 400,000 patients globally.

National Law Review
Mar 26th, 2025
Heartflow Closes $98 Million Convertible Notes Financing

Heartflow was recently named one of Fast Company's Most Innovative Companies in Medical Devices for 2025 and won the Innovation in Cardiac Imaging award at the Global Cardiovascular Awards 2025.

Hit Consultant
Jan 22nd, 2025
Heartflow And Boone Heart Institute Launch Gamefilm Registry To Study Heart Health In Retired Nfl Players

HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players. by Fred Pennic 01/22/2025 Leave a Comment. What You Should Know: – HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry. – GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.Understanding the Unique Cardiovascular Risks of Retired NFL PlayersCardiovascular disease remains the leading cause of death globally. Despite advancements in diagnostics, many heart attacks and strokes occur in individuals without prior symptoms. Early identification of high-risk individuals is critical for effective prevention and treatment. Retired NFL players often face unique cardiovascular health challenges due to the intense physical demands of their careers

GlobeNewswire
Oct 18th, 2024
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease

HeartFlow announces new Category I CPT code from the American Medical Association for ai-enabled Plaque Analysis to assess risk for coronary artery disease.